Oculis
Latest round
- Series C
Last raised
- May 2021
Total raised
- $93M
Investors
- 12
About Oculis
A. is a biopharmaceutical company that develops topical eye treatments for the anterior and posterior sections of the eye affected by ophthalmic diseases such as diabetic macular edema. The company emerged from a research collaboration of ophthalmologist Prof. Einar Stefánsson and pharmacist and chemist Prof. Thorsteinn Loftsson. Its first product OPTIREACH® achieved animal proof of concept in the same year.A agreed to merge with European Biotech Acquisition Corp. a SPAC Vehicle, for an undisclosed amount. In 2023, the company went public on NASDAQ (ticker: OCS). As of 2023, the company has 8 pipelines under development, of which two are in phase III. Its pipeline OCS-01 is based on the OPTIREACH technology, OCS-02 is a single-chain antibody fragment against TNFa and OCS-05 is a novel serum-glucocorticoid-regulated protein kinase 2 activator peptidomimetic small molecule.
Who invested in Oculis
12 investors across 5 rounds
See all investors in Oculis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oculis
Who invested in Oculis?
Oculis has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oculis raised?
Oculis has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Oculis last raise money?
Oculis's most recent round on record is a Series C, in May 2021.
What does Oculis do?
Oculis is a biotechnology company.
Where is Oculis headquartered?
Oculis is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like Oculis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Oculis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Oculis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.